home / stock / brsyf / brsyf news

BRSYF News and Press, Brainsway Ltd Ord From 03/18/24

Stock Information
Company Name: Brainsway Ltd Ord
Stock Symbol: BRSYF
Market: OTC
Website: brainsway.com
Menu
BRSYF BRSYF Quote BRSYF Short BRSYF News BRSYF Articles BRSYF Message Board
Get BRSYF Alerts

News, Short Squeeze, Breakout and More Instantly...
BRSYF - BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS(TM) Systems

BURLINGTON, Mass. and JERUSALEM, March 18, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced today that its signif...
BRSYF - BrainsWay Ltd. (BWAY) Q4 2023 Earnings Call Transcript

2024-03-06 10:04:09 ET BrainsWay Ltd. (BWAY) Q4 2023 Earnings Conference Call March 06, 2024 08:30 A.M. ET Company Participants Troy Williams - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Jeffrey Cohen - Ladenbur...

BRSYF - Brainsway beats top-line and bottom-line estimates; initiates FY24 outlook

2024-03-06 07:40:10 ET More on Brainsway BrainsWay Q4 Earnings Preview BrainsWay Is Reviving From A Deep Depression Seeking Alpha’s Quant Rating on Brainsway Historical earnings data for Brainsway Financial information for Brainsway R...

BRSYF - BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive Quarterly Net Income Providing Full-Year 2024 Revenue Guidance of $ 3 7 -$ 4 0 M illion with Continued Profitability Momentum and Ca...
BRSYF - BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will rep...

BRSYF - BrainsWay Initiates Clinical Evaluation of Rotational Field "Deep TMS 360°(TM)" Technology

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will be ...

BRSYF - BrainsWay Highlights Expanded Deep TMS(TM) Access with Growing Western U.S. Network

BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced increased collab...
BRSYF - BrainsWay Announces Continued Expansion of Deep TMS(TM) in South Korea

BURLINGTON, Mass. and JERUSALEM, Dec. 07, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced expanded availab...

BRSYF - Louisiana Insurer Expands Deep TMS(TM) Access for 1.9 Million Covered Lives

BURLINGTON, Mass. and JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Blue Cross ...

BRSYF - BrainsWay: Positive Cash Flow And Continued Growth

2023-11-20 00:01:19 ET Summary BrainsWay reported solid results in Q3 2023 and is now on the verge of sustainable profitability. BrainsWay's focus on larger organizations appears to be supporting growth and improving sales efficiency. While BrainsWay's share price has increase...
Previous 10 Next 10